Program Overview
Tuesday, April 15 to Thursday, May 8, 2025.
This course offers a thorough overview of the latest research advancements in Acute Myeloid Leukemia (AML). Attendees will gain deep knowledge and develop skills in conducting clinical, translational, and basic research specific to AML.
The course series will delve into the pathobiology of AML, offering a comprehensive exploration of its underlying mechanisms and the latest advancements in its targeted therapies. In addition, the course will highlight recent breakthroughs in targeted treatments, focusing on novel therapies specifically targeting key molecular drivers of AML.
For the detailed program, please click here.
Program Objectives
Upon the completion of the course, attendees should be able to:
- Provide an in-depth overview of the latest research advancements and clinical management of AML.
- Equip participants with the knowledge and skills necessary for conducting clinical, translational, and basic research in the context of AML.
- Explore the pathobiology of AML, focusing on its genetic mutations, molecular pathways, and cellular interactions.
- Examine recent breakthroughs in the clinical management of AML and its targeted therapies, including the development of novel treatments targeting key molecular drivers.
- Engage participants in interactive seminars, clinical case discussions, and hands-on workshops focused on advanced research methods and applied techniques.
- Stay up-to-date with the evolving landscape and clinical management of AML and offer insights into its emerging therapeutic strategies.
Target Audience
Faculty members, post-doctoral research fellows, medical fellows, graduate students and research assistants.
Date and Venue
The lectures will be delivered via an electronic platform. The workshops will be conducted Face-to-face. The duration of the course is 3 weeks.
FREE REGISTRATION!
Registration is required. Deadline to register is on Monday, April 14, 2025, at 12 pm Beirut Local Time.
Recent Comments